Index S&P 500
P/E 197.07
EPS (ttm) 0.38
Insider Own 0.14%
Shs Outstand 1.27B
Perf Week -10.08%
Market Cap 95.74B
Forward P/E 10.51
EPS next Y 7.18
Insider Trans -0.41%
Shs Float 1.27B
Perf Month -4.96%
Enterprise Value 166.39B
PEG 0.70
EPS next Q 1.00
Inst Own 89.42%
Short Float 1.48%
Perf Quarter -1.66%
Income 469.00M
P/S 0.24
EPS this Y 22.99%
Inst Trans 1.43%
Short Ratio 2.35
Perf Half Y 20.73%
Sales 393.94B
P/B 1.31
EPS next Y 7.69%
ROA 0.18%
Short Interest 18.76M
Perf YTD -4.96%
Book/sh 57.42
P/C 8.48
EPS next 5Y 14.93%
ROE 0.63%
52W High 85.15 -11.43%
Perf Year 32.73%
Cash/sh 8.89
P/FCF 15.21
EPS past 3/5Y -14.99% -6.37%
ROIC 0.32%
52W Low 53.36 41.34%
Perf 3Y -13.96%
Dividend Est. 2.66 (3.53%)
EV/EBITDA 9.69
Sales past 3/5Y 8.48% 7.75%
Gross Margin 13.85%
Volatility 4.14% 2.97%
Perf 5Y 1.60%
Dividend TTM 2.66 (3.53%)
EV/Sales 0.42
EPS Y/Y TTM -90.11%
Oper. Margin 3.19%
ATR (14) 2.51
Perf 10Y -19.83%
Dividend Ex-Date Jan 22, 2026
Quick Ratio 0.63
Sales Y/Y TTM 6.71%
Profit Margin 0.12%
RSI (14) 42.17
Recom 1.57
Dividend Gr. 3/5Y 9.07% 5.87%
Current Ratio 0.83
EPS Q/Q -4633.14%
SMA20 -4.75%
Beta 0.50
Target Price 94.88
Payout 72.76%
Debt/Eq 1.12
Sales Q/Q 7.83%
SMA50 -4.16%
Rel Volume 1.34
Prev Close 74.52
Employees 300000
LT Debt/Eq 1.02
Earnings Feb 10 BMO
SMA200 4.64%
Avg Volume 8.00M
Price 75.42
IPO Oct 01, 1952
Option/Short Yes / Yes
EPS/Sales Surpr. 17.21% 4.11%
Trades
Volume 10,708,984
Change 1.21%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-14-25 Initiated
Goldman
Buy
$91
Aug-18-25 Upgrade
UBS
Neutral → Buy
$79
Aug-14-25 Upgrade
Robert W. Baird
Neutral → Outperform
$82
Feb-13-25 Upgrade
Leerink Partners
Market Perform → Outperform
$55 → $75
Feb-12-25 Upgrade
Cantor Fitzgerald
Neutral → Overweight
Jan-30-25 Upgrade
Edward Jones
Hold → Buy
Dec-03-24 Upgrade
Deutsche Bank
Hold → Buy
$66
Nov-18-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$60 → $66
Oct-10-24 Upgrade
Barclays
Equal Weight → Overweight
$63 → $82
Oct-04-24 Upgrade
TD Cowen
Hold → Buy
$59 → $85
May-30-24 Initiated
Robert W. Baird
Neutral
$61
May-07-24 Downgrade
TD Cowen
Buy → Hold
$99 → $59
May-02-24 Downgrade
UBS
Buy → Neutral
$85 → $60
May-01-24 Downgrade
Leerink Partners
Outperform → Market Perform
$87 → $60
May-01-24 Downgrade
Cantor Fitzgerald
Overweight → Neutral
Mar-06-24 Initiated
Barclays
Equal Weight
$78
Feb-26-24 Initiated
Leerink Partners
Outperform
$88
Dec-22-23 Initiated
HSBC Securities
Buy
$94
Sep-19-23 Upgrade
Evercore ISI
In-line → Outperform
$81 → $83
Sep-12-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$80
Show Previous Ratings
Today 03:08AM
Feb-02-26 07:15AM
05:47AM
Feb-01-26 05:30PM
Jan-31-26 09:35AM
07:47AM
Loading…
07:47AM
Jan-30-26 02:23PM
09:40AM
Jan-29-26 10:38AM
09:13AM
02:19AM
Jan-28-26 05:45PM
12:35PM
12:24PM
12:07PM
07:42AM
Loading…
07:42AM
05:30AM
(The Wall Street Journal)
03:20AM
(The Wall Street Journal)
Jan-27-26 11:31PM
07:13PM
07:06PM
05:34PM
(The Wall Street Journal)
05:33PM
(The Wall Street Journal)
05:12PM
04:54PM
(The Wall Street Journal)
04:44PM
04:44PM
04:41PM
04:38PM
04:37PM
04:17PM
Loading…
04:17PM
(The Wall Street Journal)
04:15PM
04:13PM
(The Wall Street Journal)
03:27PM
03:19PM
03:17PM
03:11PM
02:51PM
02:36PM
01:35PM
12:55PM
12:44PM
12:24PM
11:55AM
11:42AM
10:35AM
(The Wall Street Journal)
10:07AM
09:55AM
09:28AM
08:52AM
07:17AM
07:16AM
(Investor's Business Daily)
07:15AM
(The Wall Street Journal)
07:09AM
06:34AM
(The Wall Street Journal)
06:23AM
05:57AM
05:44AM
05:40AM
05:00AM
04:37AM
(The Wall Street Journal)
04:16AM
(The Wall Street Journal)
01:39AM
Jan-26-26 10:15PM
06:56PM
(The Wall Street Journal)
05:11PM
(The Wall Street Journal)
04:47PM
01:12PM
09:00AM
03:55AM
01:46AM
Jan-25-26 12:39PM
Jan-24-26 09:21AM
09:00AM
Jan-23-26 05:25PM
04:42PM
04:38PM
01:31PM
09:12AM
08:00AM
03:36AM
Jan-22-26 05:45PM
11:31AM
11:07AM
09:16AM
08:00AM
06:58AM
Jan-21-26 04:20PM
11:21AM
08:30AM
Jan-19-26 07:38AM
Jan-16-26 10:26AM
02:30AM
Jan-15-26 05:45PM
12:30PM
12:04PM
Jan-14-26 10:55AM
09:00AM
Jan-13-26 09:40AM
09:00AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Finucane Anne A. Director Aug 20 '25 Sale 71.02 7,500 532,650 22,156 Aug 29 04:29 PM Finucane Anne A. Director Aug 20 '25 Proposed Sale 70.97 7,500 532,275 Aug 19 06:57 PM SANSONE GUY P Director Jun 05 '25 Buy 63.70 1,570 100,009 12,007 Jun 09 08:22 AM ROBBINS LARRY Director May 02 '25 Sale 67.86 2,276,068 154,444,758 9,670,731 May 06 04:15 PM ROBBINS LARRY Director May 05 '25 Sale 67.41 1,323,932 89,249,945 8,346,799 May 06 04:15 PM ROBBINS LARRY Director May 06 '25 Sale 66.67 150,000 10,000,710 8,196,799 May 06 04:15 PM Shah Prem S EVP and Group President Mar 17 '25 Option Exercise 62.21 846 52,630 43,190 Mar 18 04:51 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Option Exercise 62.21 7,513 467,384 15,907 Mar 07 04:56 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Sale 66.35 7,513 498,488 8,394 Mar 07 04:56 PM Clark James David Officer Mar 05 '25 Proposed Sale 66.35 7,513 498,489 Mar 05 05:25 PM Mahoney Michael F Director Feb 18 '25 Buy 66.70 30,000 2,001,000 39,356 Feb 19 12:35 PM